Stock 600998 JOINTOWN PHARMACEUTICAL GROUP CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Jointown Pharmaceutical Group Co., Ltd

Equities

600998

CNE100000W45

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 07/05/2024 BST 		5-day change 1st Jan Change
8.09 CNY -0.98% Intraday chart for Jointown Pharmaceutical Group Co., Ltd -1.46% +15.41%
04-29 Jointown Pharma's Q1 Profit, Revenue Fall 4% MT
04-29 Jointown Pharmaceutical Group's 2023 Profit Jumps 4% MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jointown Pharma's Q1 Profit, Revenue Fall 4%
MT
Jointown Pharmaceutical Group's 2023 Profit Jumps 4%
MT
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Jointown Pharmaceutical Sets Up Joint AI Lab with Peking University's Wuhan Campus
MT
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Jointown Pharma's Unit Gets Nod for Registration of Acarbose Tablets
MT
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.
CI
Jointown Pharmaceutical Group Co., Ltd's Equity Buyback announced on April 26, 2022, has expired with 36,138,098 shares, representing 1.94% for CNY 425.67 million.
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.
CI
Jointown Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 600 million worth of its shares.
CI
Jointown Pharmaceutical Group Co., Ltd authorizes a Buyback Plan.
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Jointown Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600998 Stock
  4. News Jointown Pharmaceutical Group Co., Ltd
  5. Highlights